Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -1,181 | -1,544 | -2,455 | -3,028 | -17,332 |
Depreciation Amortization | N/A | N/A | N/A | N/A | 1,936 |
Accounts payable and accrued liabilities | -148 | 27 | -208 | -1,944 | -12,081 |
Other Working Capital | -64 | 176 | 1,984 | -1,180 | -11,664 |
Other Operating Activity | -129 | -401 | 461 | 1,527 | 7,773 |
Operating Cash Flow | $-1,522 | $-1,742 | $-218 | $-4,625 | $-31,368 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -12,588 | N/A | N/A | N/A | 51,500 |
PPE Investments | N/A | N/A | N/A | N/A | 2,025 |
Net Acquisitions | N/A | N/A | N/A | N/A | 5,000 |
Sale Of Investment | N/A | N/A | N/A | N/A | 7,800 |
Other Investing Activity | 139 | 445 | 144 | 2,139 | 3,500 |
Investing Cash Flow | $-12,449 | $445 | $144 | $2,139 | $69,825 |
Cash Flows From Financing Activities | |||||
Debt Repayment | N/A | N/A | N/A | N/A | -15,000 |
Common Stock Issued | 521 | 6,533 | 239 | N/A | 145 |
Dividend Paid | N/A | N/A | N/A | N/A | -26,700 |
Other Financing Activity | 0 | 0 | 0 | -56 | -985 |
Financing Cash Flow | $521 | $6,533 | $239 | $-56 | $-42,540 |
Beginning Cash Position | 19,439 | 14,203 | 14,038 | 16,580 | 20,663 |
End Cash Position | 5,989 | 19,439 | 14,203 | 14,038 | 16,580 |
Net Cash Flow | $-13,450 | $5,236 | $165 | $-2,542 | $-4,083 |
Free Cash Flow | |||||
Operating Cash Flow | -1,522 | -1,742 | -218 | -4,625 | -31,368 |
Free Cash Flow | -1,522 | -1,742 | -218 | -4,625 | -31,368 |